Triton Acquires Majority Stake in Atnahs

August 8, 2019

Funds advised by Triton Partners have acquired a majority stake in Atnahs, a UK-based specialty pharmaceutical business that acquires, develops and markets mature branded medicines. Atnahs operates a portfolio of over 800 SKUs across more than 130 markets; terms of the transaction were not disclosed.

Targets
Atnahs
Industry
Pharmaceuticals
Location
Essex, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.